GT Biopharma (GTBP) had the highest return between September 2, 2013 and September 27, 2013 by a US stock, returning 512.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 9/2/2013 - 9/27/2013 | 512.9% |
Scienture (SCNX) | 9/2/2013 - 9/27/2013 | 285.71% |
InnovAge (INNV) | 9/2/2013 - 9/27/2013 | 183.58% |
Daqo New Energy Corp ADR (DQ) | 9/2/2013 - 9/27/2013 | 163.21% |
Geron (GERN) | 9/2/2013 - 9/27/2013 | 153.44% |
Ammo (POWW) | 9/2/2013 - 9/27/2013 | 120.99% |
Omeros (OMER) | 9/2/2013 - 9/27/2013 | 93.33% |
Rockwell Medical (RMTI) | 9/2/2013 - 9/27/2013 | 91.64% |
Fennec Pharmaceuticals (FENC) | 9/2/2013 - 9/27/2013 | 88.51% |
Retractable Technologies (RVP) | 9/2/2013 - 9/27/2013 | 86.21% |
Actinium Pharmaceuticals (ATNM) | 9/2/2013 - 9/27/2013 | 77.78% |
Nixxy (NIXX) | 9/2/2013 - 9/27/2013 | 76.82% |
Taoping (TAOP) | 9/2/2013 - 9/27/2013 | 75.97% |
Cocrystal Pharma (COCP) | 9/2/2013 - 9/27/2013 | 75.56% |
Lithium Argentina (LAR) | 9/2/2013 - 9/27/2013 | 73.45% |
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN) | 9/2/2013 - 9/27/2013 | 69.43% |
Kandi Technologies (KNDI) | 9/2/2013 - 9/27/2013 | 67.85% |
Celldex Therapeutics (CLDX) | 9/2/2013 - 9/27/2013 | 63.01% |
Ryvyl (RVYL) | 9/2/2013 - 9/27/2013 | 62.5% |
Catalyst Pharmaceuticals (CPRX) | 9/2/2013 - 9/27/2013 | 62.31% |
Globalstar, Inc Common Stock (GSAT) | 9/2/2013 - 9/27/2013 | 60.37% |
Xpel (XPEL) | 9/2/2013 - 9/27/2013 | 58.94% |
Perma-Fix Environmental Svcs (PESI) | 9/2/2013 - 9/27/2013 | 57.92% |
Gogo (GOGO) | 9/2/2013 - 9/27/2013 | 56.1% |
Himax Technologies (HIMX) | 9/2/2013 - 9/27/2013 | 55.77% |
